TCTMD: the most comprehensive online resource for interventional cardiology and beyond, with news coverage spanning the entire field of cardiovascular disease.

Thank you for joining TCTMD, the leading community for interventional cardiovascular news and education and beyond. When you registered with us today, you joined tens of thousands of other clinicians and industry professionals around the world who utilize our platform to stay update-to-date on the latest developments in interventional cardiology and endovascular medicine.

27 Oct 2024 · TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting the next wave of innovation in research and education that will help doctors save and improve the quality of their patients’ lives.

17 Oct 2024 · TCT 2024, the annual scientific showcase of interventional cardiovascular medicine, is returning once again to Washington, DC. The 4-day meeting starts Sunday, October 27, 2024, and will involve more than 1,400 faculty spread out across 161 different sessions, including 33 live endovascular, structural, and coronary cases. Three sessions, one per day, …

TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting the next wave of innovation in research and education that will help doctors save and improve the quality of their patients’ lives.

1 day ago · February 5, 2025 | Looking at the REVIVED-BCIS2 results, Divaka Perera and C. Michael Gibson discuss the relationship between myocardial viability, PCI, and outcomes. Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the ...

4 Nov 2021 · TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting the next wave of innovation in research and education that will help doctors save and improve the quality of their patients’ lives.

In Memoriam Jason R. Kahn, the former News Editor of TCTMD, worked at CRF for 11 years until his death in 2014 at age 45. In his tenure, Kahn transformed the cardiology news coverage of TCTMD from a single-person operation into a vibrant editorial team. He received an undergraduate degree in Communications from the University of Michigan and an MA in …

26 Oct 2023 · SAN FRANCISCO, CA—Patients with severe tricuspid regurgitation (TR) treated with transcatheter valve replacement experienced a significant improvement in TR grade and had “meaningful” improvements in functional status and symptoms, according to data from the first 150 patients in the TRISCEND II study.

5 Dec 2024 · There is a growing recognition of the prevalence and outcomes associated with tricuspid regurgitation, whether in isolation or with concomitant diseases. This program will focus on defining the burden of disease, outlining current guideline directed medical therapy and discussing the recent evidence for transcatheter therapies. Gaps in our current understanding …